Biocept, Inc. (BIOC)
NASDAQ: BIOC · IEX Real-Time Price · USD
0.964
+0.016 (1.69%)
At close: Jun 29, 2022 4:00 PM
1.000
+0.036 (3.713%)
After-hours:
Jun 29, 2022 7:27 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
|
61.25 | 27.46 | 5.53 | 3.25 | 5.07 | 3.22 | 0.61 | 0.13 | 0.13 | 0.11 | Upgrade
|
Revenue Growth (YoY)
|
123.04% | 396.71% | 70.09% | -35.88% | 57.26% | 428.46% | 357.15% | -0.62% | 22.84% | 10288.69% | Upgrade
|
Cost of Revenue
|
37.76 | 21.34 | 10.98 | 10.05 | 9.35 | 6.92 | 4.6 | 2.17 | 2.33 | 1.2 | Upgrade
|
Gross Profit
|
23.49 | 6.12 | -5.45 | -6.8 | -4.28 | -3.7 | -3.99 | -2.04 | -2.2 | -1.09 | Upgrade
|
Selling, General & Admin
|
20.93 | 16.37 | 12.91 | 12.99 | 13.53 | 11.61 | 9.57 | 7.34 | 2.66 | 2.85 | Upgrade
|
Research & Development
|
4.96 | 5.22 | 4.7 | 4.47 | 3.36 | 2.71 | 2.86 | 4.5 | 3.09 | 6.56 | Upgrade
|
Operating Expenses
|
25.89 | 21.59 | 17.61 | 17.46 | 16.9 | 14.33 | 12.42 | 11.84 | 5.75 | 9.41 | Upgrade
|
Operating Income
|
-2.41 | -15.47 | -23.06 | -24.26 | -21.17 | -18.03 | -16.41 | -13.87 | -7.94 | -10.5 | Upgrade
|
Interest Expense / Income
|
0.29 | 0.24 | 0.25 | 0.31 | 0.48 | 0.53 | 0.64 | 1.79 | 2.07 | 2.19 | Upgrade
|
Other Expense / Income
|
0 | 2.1 | 1.83 | 0 | -0.05 | -0.15 | -0.1 | 0.2 | -0.78 | -0.43 | Upgrade
|
Pretax Income
|
-2.7 | -17.81 | -25.14 | -24.57 | -21.61 | -18.4 | -16.95 | -15.86 | -9.23 | -12.26 | Upgrade
|
Income Tax
|
0.13 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Net Income
|
-2.82 | -17.81 | -25.14 | -24.57 | -21.61 | -18.4 | -16.95 | -15.87 | -9.23 | -12.26 | Upgrade
|
Preferred Dividends
|
0 | 0 | 0.12 | 0.64 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Net Income Common
|
-2.82 | -17.81 | -25.26 | -25.21 | -21.61 | -18.4 | -16.95 | -15.87 | -9.23 | -12.26 | Upgrade
|
Shares Outstanding (Basic)
|
15 | 12 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Shares Outstanding (Diluted)
|
15 | 12 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Shares Change
|
24.74% | 473.32% | 638.35% | 205.28% | 187.08% | 73.74% | 313.71% | 2099.01% | 13.48% | 41.27% | Upgrade
|
EPS (Basic)
|
-0.19 | -1.50 | -12.23 | -90.10 | -235.80 | -576.30 | -921.00 | -3.00 | -45.00 | -68.00 | Upgrade
|
EPS (Diluted)
|
-0.19 | -1.50 | -12.23 | -90.10 | -235.80 | -576.30 | -921.00 | -3.00 | -45.00 | -68.00 | Upgrade
|
Free Cash Flow Per Share
|
0.14 | -1.74 | -11.51 | -80.41 | -229.66 | -505.78 | -833.67 | -3.00 | -30.00 | -48.00 | Upgrade
|
Gross Margin
|
38.34% | 22.30% | -98.56% | -209.26% | -84.37% | -114.70% | -653.58% | -1526.91% | -1635.56% | -999.56% | Upgrade
|
Operating Margin
|
-3.93% | -56.33% | -417.05% | -746.35% | -417.76% | -559.25% | -2690.70% | -10399.07% | -5917.86% | -9610.37% | Upgrade
|
Profit Margin
|
-4.61% | -64.86% | -456.89% | -775.56% | -426.42% | -570.86% | -2779.03% | -11892.25% | -6877.86% | -11217.53% | Upgrade
|
Free Cash Flow Margin
|
3.46% | -75.21% | -430.21% | -692.26% | -415.31% | -501.02% | -2511.85% | -11221.06% | -4620.71% | -7882.83% | Upgrade
|
Effective Tax Rate
|
-4.63% | 0.00% | 0.00% | -0.01% | -0.04% | -0.01% | -0.01% | -0.01% | -0.01% | -0.01% | Upgrade
|
EBITDA
|
0.23 | -16.57 | -24.11 | -23.46 | -20.55 | -17.55 | -16.05 | -13.82 | -6.9 | -9.71 | Upgrade
|
EBITDA Margin
|
0.37% | -60.34% | -436.18% | -721.71% | -405.39% | -544.49% | -2631.04% | -10361.40% | -5136.70% | -8880.73% | Upgrade
|
Depreciation & Amortization
|
2.64 | 1 | 0.77 | 0.8 | 0.58 | 0.32 | 0.26 | 0.25 | 0.27 | 0.37 | Upgrade
|
EBIT
|
-2.41 | -17.57 | -24.89 | -24.26 | -21.12 | -17.87 | -16.31 | -14.07 | -7.16 | -10.07 | Upgrade
|
EBIT Margin
|
-3.93% | -63.98% | -450.17% | -746.35% | -416.75% | -554.48% | -2673.90% | -10549.68% | -5335.26% | -9215.23% | Upgrade
|
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).